A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases.Alison Stopeck, Ada Braun, Denise A. Yardley et al.|Cancer Research|2009Cited by 21